This inventor holds 14 USPTO granted patents and 17 published patent applications, plus 2 CIPO patents and 3 EPO patents. Top assignees: Alba Therapeutics Corporation, Cerecor, Inc., Merck Sharp + Dohme Corp.. Active years: 2011-2025.
Company Filing History:
9 out of 16 
4 out of 6 
4 out of 2,405 
Years Active: 2011-2025
Title: **Blake Paterson: Innovator in Pharmaceutical Compounds**
Introduction
Blake Paterson is an accomplished inventor based in Baltimore, MD, who has made significant contributions to the field of pharmaceuticals. With a portfolio boasting 13 patents, he has been at the forefront of innovation, focusing on novel compounds and their applications in treating various medical conditions.
Latest Patents
Among his latest patents is a notable work on "Compounds, compositions and methods," which discloses specific polymorphic forms of Compound (I). This invention highlights the discovery that Compound (I) can exist in multiple crystalline forms, with Form II exhibiting greater thermodynamic stability. As a result, Form II is likely more suitable for bulk preparation and handling. The methods developed not only ensure high purity but also enable large-scale production. Furthermore, Form II has shown safety and efficacy in animal studies for treating depressive disorders, particularly noting improved absorption when micronized.
Another significant innovation by Paterson involves "Use of tight junction antagonists in the treatment of acute lung injury and acute respiratory distress syndrome." This patent outlines methods for administering tight junction antagonists directly to the lung of a patient in need, showcasing his commitment to addressing critical health challenges.
Career Highlights
Throughout his career, Blake Paterson has contributed to renowned organizations, including Alba Therapeutics Corporation and Cerecor, Inc. His innovative research has played a pivotal role in the development of therapeutic solutions, addressing unmet medical needs.
Collaborations
Paterson has collaborated with esteemed professionals such as Mark J. Ginski and Alessio Fasano, further enhancing the depth of his research and the impact of his inventions. These partnerships have been crucial in bringing his innovations from concept to practical application.
Conclusion
Blake Paterson stands out as a key figure in pharmaceutical innovation, with a strong focus on developing compounds that significantly impact healthcare. His contributions and collaborative efforts continue to pave the way for advancements in treatments for various disorders, marking him as an influential inventor in the medical field.